Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo

Tissue Engineering - Part A

Volumn 17, Issue 11-12, 2011, Pages 1605-1614

  Kawamoto, Shunsuke ^a   Flynn, Jerald P ^b   Shi, Qun ^c   Sakr, Sana W ^d   Luo, Jun ^e   Allen, Margaret D ^e  

^a TOHOKU UNIVERSITY   (Japan)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HOPE HEART INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; CELL DEATH; COBALT; FUNCTIONAL POLYMERS; GRAFTS; PORPHYRINS; TIN; TISSUE; TISSUE ENGINEERING;

ADDITIONAL CONTROL; APOPTOSIS; CAPILLARY NETWORK; CARDIOMYOCYTES; CELL SURVIVAL; CONTROL GROUPS; EXTRACELLULAR MATRICES; FUNCTIONAL RECOVERY; HEME OXYGENASE-1; IN-VIVO; PROTOPORPHYRINS; REPAIR STRATEGY;

THREE DIMENSIONAL;

MURINAE;

HEME OXYGENASE 1; PROTOPORPHYRIN; PROTOPORPHYRIN COBALT; TROPONIN T;

ANGIOGENESIS; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL SIZE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; HEART ATRIUM; HEART CONTRACTION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; IMPLANT; MALE; METABOLISM; MOUSE; ORGAN CULTURE TECHNIQUE; PATHOLOGY; SUBCUTANEOUS TISSUE; TRANSPLANTATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL SIZE; CELL SURVIVAL; ENZYME INDUCTION; HEART ATRIA; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN CULTURE TECHNIQUES; PROTOPORPHYRINS; SUBCUTANEOUS TISSUE; TROPONIN T;

EID: 79957594153     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0447     Document Type: Article

References (75)

1. Reinecke, H., Zhang, M., Bartosek, T., and Murry, C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100, 193, 1999.
2. Murry, C.E., Jennings, R.B., and Reimer, K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124, 1986.
3. Bolli, R. The late phase of preconditioning. Circ Res 87, 972, 2000.
4. Dawn, B., and Bolli, R. HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol 289, H522, 2005.
5. Wu, L., and Wang, R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57, 585, 2005.
6. Hausenloy, D.J., and Yellon, D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70, 240, 2006.
7. Burley, D.S., Ferdinandy, P., and Baxter, G.F. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152, 855, 2007.
8. Bilban, M., Haschemi, A., Wegiel, B., Chin, B.Y., Wagner, O., and Otterbein, L.E. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 86, 267, 2008.
9. Fujimoto, H., Ohno, M., Ayabe, S., Kobayashi, H., Ishizaka, N., Kimura, H., Yoshida, K., and Nagai, R. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 24, 1848, 2004.
10. Zhang, X., Shan, P., Alam, J., Fu, X.Y., and Lee, P.J. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxiareoxygenation injury. J Biol Chem 280, 8714, 2005.
11. Gozzelino, R., Jeney, V., and Soares, M.P. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50, 323, 2010.
12. Wang, G., Hamid, T., Keith, R.J., Zhou, G., Partridge, C.R., Xiang, X., Kingery, J.R., Lewis, R.K., Li, Q., Rokosh, D.G., Ford, R., Spinale, F.G., Riggs, D.W., Srivastava, S., Bhatnagar, A., Bolli, R., and Prabhu, S.D. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121, 1912, 2010.
13. Suliman, H.B., Carraway, M.S., Tatro, L.G., and Piantadosi, C.A. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 120, 299, 2007.
14. Suliman, H.B., Carraway, M.S., Ali, A.S., Reynolds, C.M., Welty-Wolf, K.E., and Piantadosi, C.A. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 117, 3730, 2007.
15. Clark, J.E., Foresti, R., Sarathchandra, P., Kaur, H., Green, C.J., and Motterlini, R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278, H643, 2000.
16. Baranano, D.E., Rao, M., Ferris, C.D., and Snyder, S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99, 16093, 2002.
17. Pachori, A.S., Smith, A., McDonald, P., Zhang, L., Dzau, V.J., and Melo, L.G. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol 43, 580, 2007.
18. Ollinger, R., Wang, H., Yamashita, K., Wegiel, B., Thomas, M., Margreiter, R., and Bach, F.H. Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal 9, 2175, 2007.
19. Bussolati, B., Ahmed, A., Pemberton, H., Landis, R.C., Di Carlo, F., Haskard, D.O., and Mason, J.C. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103, 761, 2004.
20. Dulak, J., Deshane, J., Jozkowicz, A., and Agarwal, A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117, 231, 2008.
21. Lakkisto, P., Kyto, V., Forsten, H., Siren, J.M., Segersvard, H., Voipio-Pulkki, L.M., Laine, M., Pulkki, K., and Tikkanen, I. Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1a, SDF-1a and VEGF-B. Eur J Pharmacol 635, 156, 2010.
22. Ockaili, R., Natarajan, R., Salloum, F., Fisher, B.J., Jones, D., Fowler, A.A., 3rd, and Kukreja, R.C. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol 289, H542, 2005.
23. Tang, Y.L., Qian, K., Zhang, Y.C., Shen, L., and Phillips, M.I. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo. J Cardiovasc Pharmacol Ther 10, 251, 2005.
24. Hangaishi, M., Ishizaka, N., Aizawa, T., Kurihara, Y., Taguchi, J., Nagai, R., Kimura, S., and Ohno, M. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/ reperfusion in vivo. Biochem Biophys Res Commun 279, 582, 2000.
25. Liu, X., Pachori, A.S., Ward, C.A., Davis, J.P., Gnecchi, M., Kong, D., Zhang, L., Murduck, J., Yet, S.F., Perrella, M.A., Pratt, R.E., Dzau, V.J., and Melo, L.G. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J 20, 207, 2006.
26. Liu, X., Simpson, J.A., Brunt, K.R., Ward, C.A., Hall, S.R., Kinobe, R.T., Barrette, V., Tse, M.Y., Pang, S.C., Pachori, A.S., Dzau, V.J., Ogunyankin, K.O., and Melo, L.G. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. Am J Physiol Heart Circ Physiol 293, H48, 2007.
27. Jadhav, A., Torlakovic, E., and Ndisang, J. Interaction among heme oxygenase, nuclear factor-kB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 52, 910, 2008.
28. Kappas, A., and Drummond, G.S. Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest 77, 335, 1986.
29. Shan, Y., Lambrecht, R.W., Donohue, S.E., and Bonkovsky, H.L. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J 20, 2651, 2006.
30. Morita, T., Perrella, M.A., Lee, M.E., and Kourembanas, S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92, 1475, 1995.
31. Bader, D., Masaki, T., and Fischman, D.A. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol 95, 763, 1982.
32. Jones, W.K., Grupp, I.L., Doetschman, T., Grupp, G., Osinska, H., Hewett, T.E., Boivin, G., Gulick, J., Ng, W.A., and Robbins, J. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 98, 1906, 1996.
33. Yoshinaga, T., Sassa, S., and Kappas, A. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation. J Biol Chem 257, 7778, 1982.
34. Veinot, J.P., Harrity, P.J., Gentile, F., Khandheria, B.K., Bailey, K.R., Eickholt, J.T., Seward, J.B., Tajik, A.J., and Edwards, W.D. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 96, 3112, 1997.
35. Jockusch, H., Fuchtbauer, E.M., Fuchtbauer, A., Leger, J.J., Leger, J., Maldonado, C.A., and Forssmann, W.G. Long-term expression of isomyosins and myoendocrine functions in ectopic grafts of atrial tissue. Proc Natl Acad Sci USA 83, 7325, 1986.
36. Okawa, H., Horimoto, H., Mieno, S., Nomura, Y., Yoshida, M., and Shinjiro, S. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts. Mol Cell Biochem 248, 171, 2003.
37. Kasama, S., Toyama, T., Hatori, T., Sumino, H., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., and Kurabayashi, M. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 49, 667, 2007.
38. Li, P., Wang, D., Lucas, J., Oparil, S., Xing, D., Cao, X., Novak, L., Renfrow, M.B., and Chen, Y.F. Atrial natriuretic peptide inhibits transforming growth factor b-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102, 185, 2008.
39. Eppenberger, H.M., and Zuppinger, C. In vitro reestablishment of cell-cell contacts in adult rat cardiomyocytes. Functional role of transmembrane components in the formation of new intercalated disk-like cell contacts. FASEB J 13 Suppl, S83, 1999.
40. Laugwitz, K.L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., Lin, L.Z., Cai, C.L., Lu, M.M., Reth, M., Platoshyn, O., Yuan, J.X., Evans, S., and Chien, K.R. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647, 2005.
41. Hsieh, P.C., Segers, V.F., Davis, M.E., MacGillivray, C., Gannon, J., Molkentin, J.D., Robbins, J., and Lee, R.T. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 13, 970, 2007.
42. Smith, R.R., Barile, L., Cho, H.C., Leppo, M.K., Hare, J.M., Messina, E., Giacomello, A., Abraham, M.R., and Marban, E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896, 2007.
43. Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R.W., Lecapitaine, N., Cascapera, S., Beltrami, A.P., D'Alessandro, D.A., Zias, E., Quaini, F., Urbanek, K., Michler, R.E., Bolli, R., Kajstura, J., Leri, A., and Anversa, P. Human cardiac stem cells. Proc Natl Acad Sci USA 104, 14068, 2007.
44. Urbanek, K., Cesselli, D., Rota, M., Nascimbene, A., De Angelis, A., Hosoda, T., Bearzi, C., Boni, A., Bolli, R., Kajstura, J., Anversa, P., and Leri, A. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 103, 9226, 2006.
45. Hosoda, T., D'Amario, D., Cabral-Da-Silva, M.C., Zheng, H., Padin-Iruegas, M.E., Ogorek, B., Ferreira-Martins, J., Yasuzawa-Amano, S., Amano, K., Ide-Iwata, N., Cheng, W., Rota, M., Urbanek, K., Kajstura, J., Anversa, P., and Leri, A. Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci USA 106, 17169, 2009.
46. Okita, K., Ichisaka, T., and Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313, 2007.
47. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, II, and Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917, 2007.
48. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., and Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101, 2008.
49. Yi, B.A., Wernet, O., and Chien, K.R. Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest 120, 20, 2010.
50. Sakai, T., Li, R.K., Weisel, R.D., Mickle, D.A., Kim, E.J., Tomita, S., Jia, Z.Q., and Yau, T.M. Autologous heart cell transplantation improves cardiac function after myocardial injury. Ann Thorac Surg 68, 2074, 1999.
51. Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., and Murry, C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33, 907, 2001.
52. Laflamme, M.A., Gold, J., Xu, C., Hassanipour, M., Rosler, E., Police, S., Muskheli, V., and Murry, C.E. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167, 663, 2005.
53. Laflamme, M.A., Chen, K.Y., Naumova, A.V., Muskheli, V., Fugate, J.A., Dupras, S.K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., O'Sullivan, C., Collins, L., Chen, Y., Minami, E., Gill, E.A., Ueno, S., Yuan, C., Gold, J., and Murry, C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25, 1015, 2007.
54. Tang, Y.L., Tang, Y., Zhang, Y.C., Qian, K., Shen, L., and Phillips, M.I. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46, 1339, 2005.
55. Narmoneva, D.A., Vukmirovic, R., Davis, M.E., Kamm, R.D., and Lee, R.T. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110, 962, 2004.
56. Naito, H., Melnychenko, I., Didie, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., Eschenhagen, T., and Zimmermann, W.H. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114, I72, 2006.
57. Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I.H., Gepstein, L., and Levenberg, S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 100, 263, 2007.
58. Stevens, K.R., Kreutziger, K.L., Dupras, S.K., Korte, F.S., Regnier, M., Muskheli, V., Nourse, M.B., Bendixen, K., Reinecke, H., and Murry, C.E. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 106, 16568, 2009.
59. Tongers, J., Fiedler, B., Kö nig, D., Kempf, T., Klein, G., Heineke, J., Kraft, T., Gambaryan, S., Lohmann, S.M., Drexler, H., and Wollert, K.C. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. Cardiovasc Res 63, 545, 2004.
60. Yamashita, T., Sekiguchi, A., Iwasaki, Y.K., Sagara, K., Hatano, S., Iinuma, H., Aizawa, T., and Fu, L.T. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria. Circulation 108, 2450, 2003.
61. Hickey, M.J., Wilson, Y., Hurley, J.V., and Morrison, W.A. Mode of vascularization of control and basic fibroblast growth factor-stimulated prefabricated skin flaps. Plast Reconstr Surg 101, 1296, 1998.
62. Gibot, L., Galbraith, T., Huot, J., and Auger, F.A. A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. Tissue Eng Part A 16, 3199, 2010 .
63. Lesman, A., Habib, M., Caspi, O., Gepstein, A., Arbel, G., Levenberg, S., and Gepstein, L. Transplantation of a tissueengineered human vascularized cardiac muscle. Tissue Eng Part A 16, 115, 2010.
64. Balla, G., Jacob, H.S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J.W., and Vercellotti, G.M. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267, 18148, 1992.
65. Brouard, S., Otterbein, L.E., Anrather, J., Tobiasch, E., Bach, F.H., Choi, A.M., and Soares, M.P. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192, 1015, 2000.
66. Dulak, J., Jozkowicz, A., Foresti, R., Kasza, A., Frick, M., Huk, I., Green, C.J., Pachinger, O., Weidinger, F., and Motterlini, R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4, 229, 2002.
67. Shimizu, T., Sekine, H., Yang, J., Isoi, Y., Yamato, M., Kikuchi, A., Kobayashi, E., and Okano, T. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J 20, 708, 2006.
68. Melo, L.G., Agrawal, R., Zhang, L., Rezvani, M., Mangi, A.A., Ehsan, A., Griese, D.P., Dell'Acqua, G., Mann, M.J., Oyama, J., Yet, S.F., Layne, M.D., Perrella, M.A., and Dzau, V.J. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105, 602, 2002.
69. Figueiredo, A.M., Poggetti, R.S., Quintavalle, F.G., Fontes, B., Dalva, M., Younes, R.N., Jatene, F.B., and Birolini, D. Isolated right atrial appendage (RAA) rupture in blunt trauma-a case report and an anatomic study comparing RAA and right atrium (RA) wall thickness. World J Emerg Surg 2, 5, 2007.
70. Kikuchi, K., McDonald, A.D., Sasano, T., and Donahue, J.K. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation 111, 264, 2005.
71. Clark, J.E., Naughton, P., Shurey, S., Green, C.J., Johnson, T.R., Mann, B.E., Foresti, R., and Motterlini, R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93, e2, 2003.
72. Stein, A.B., Guo, Y., Tan, W., Wu, W.J., Zhu, X., Li, Q., Luo, C., Dawn, B., Johnson, T.R., Motterlini, R., and Bolli, R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38, 127, 2005.
73. Kotsch, K., Francuski, M., Pascher, A., Klemz, R., Seifert, M., Mittler, J., Schumacher, G., Buelow, R., Volk, H.D., Tullius, S.G., Neuhaus, P., and Pratschke, J. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 6, 477, 2006.
74. Katori, M., Buelow, R., Ke, B., Ma, J., Coito, A.J., Iyer, S., Southard, D., Busuttil, R.W., and Kupiec-Weglinski, J.W. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73, 287, 2002.
75. Akamatsu, Y., Haga, M., Tyagi, S., Yamashita, K., Graca-Souza, A.V., Ollinger, R., Czismadia, E., May, G.A., Ifedigbo, E., Otterbein, L.E., Bach, F.H., and Soares, M.P. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 18, 771, 2004.